Decreased Expression of LKB1 Correlates with Poor Prognosis in Hepatocellular Carcinoma Patients Undergoing Hepatectomy |
Huang, Yue-Han
(Department of Hepatobiliary, The First Affiliated Hospital of Wenzhou Medical College)
Chen, Zhen-Kun (Department of Hepatobiliary, The First Affiliated Hospital of Wenzhou Medical College) Huang, Ka-Te (Department of Pathology, The First Affiliated Hospital of Wenzhou Medical College) Li, Peng (Department of Pathology, The First Affiliated Hospital of Wenzhou Medical College) He, Bin (Department of Hepatobiliary, The First Affiliated Hospital of Wenzhou Medical College) Guo, Xu (Department of Hepatobiliary, The First Affiliated Hospital of Wenzhou Medical College) Zhong, Jun-Qiao (Department of Hepatobiliary, The First Affiliated Hospital of Wenzhou Medical College) Zhang, Qi-Yu (Department of Hepatobiliary, The First Affiliated Hospital of Wenzhou Medical College) Shi, Hong-Qi (Department of Hepatobiliary, The First Affiliated Hospital of Wenzhou Medical College) Song, Qi-Tong (Department of Hepatobiliary, The First Affiliated Hospital of Wenzhou Medical College) Yu, Zheng-Ping (Department of Hepatobiliary, The First Affiliated Hospital of Wenzhou Medical College) Shan, Yun-Feng (Department of Hepatobiliary, The First Affiliated Hospital of Wenzhou Medical College) |
1 | Avizienyte E, Loukola A, Roth S, et al (1999). LKB1 somatic mutations in sporadic tumors. Am J Pathol, 154, 677-81. DOI ScienceOn |
2 | Cha HJ, Kim J, Hong SM, et al(2012). Overexpression of renal tumor antigen is associated with tumor invasion and poor prognosis of hepatocellular carcinoma. Ann Surg Oncol, 19, 404-11. DOI ScienceOn |
3 | Chen HP, Shieh JJ, Chang CC, et al (2013). Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies. Gut, 62, 606-15. DOI ScienceOn |
4 | Esteller M, Avizienyte E, Corn PG, et al (2000). Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome. Oncogene, 19, 164-8. DOI ScienceOn |
5 | Fenton H, Carlile B, Montgomery EA, et al (2006). LKB1 protein expression in human breast cancer. Appl Immunohistochem Mol Morphol, 14, 146-53. DOI ScienceOn |
6 | Fernandez P, Carretero J, Medina PP, et al (2004). Distinctive gene expression of human lung adenocarcinomas carrying LKB1 mutations. Oncogene, 23, 5084-91. DOI ScienceOn |
7 | Gao Y, Ge G, Ji H(2011). LKB1 in lung cancerigenesis: a serine/threonine kinase as tumor suppressor. Protein Cell, 2, 99-107. DOI ScienceOn |
8 | Herrmann JL, Byekova Y, Athar M (2011). Liver kinase B1 (LKB1) in the pathogenesis of epithelial cancers. Cancer Lett, 306, 1-9. DOI ScienceOn |
9 | Hezel AF, Gurumurthy S, Granot Z, et al (2008). Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms. Mol Cell Biol, 28, 2414-25. DOI ScienceOn |
10 | Kim DW, Chung HK, Park KC, et al (2007). Tumor suppressor LKB1 inhibits activation of signal transducer and activator of transcription 3 (STAT3) by thyroid oncogenic tyrosine kinase rearranged in transformation (RET)/papillary thyroid carcinoma (PTC). Mol Endocrinol, 21, 3039-49. DOI ScienceOn |
11 | Li PD, Zhang WJ, Zhang MY, et al (2012). Overexpression of RPS6KB1 predicts worse prognosis in primary HCC patients. Med Oncol, 29, 3070-6. DOI ScienceOn |
12 | Miyoshi H, Deguchi A, Nakau M, et al (2009). Hepatocellular carcinoma development induced by conditional beta-catenin activation in Lkb1+/- mice. Cancer Sci, 100, 2046-53. DOI ScienceOn |
13 | Nagalingam A, Arbiser JL, Bonner MY, Saxena NK, Sharma D (2012). Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis. Breast Cancer Res, 14, R35. DOI ScienceOn |
14 | Nakau M, Miyoshi H, Seldin MF, et al (2002). Hepatocellular carcinoma caused by loss of heterozygosity in Lkb1 gene knockout mice. Cancer Res, 62, 4549-53. |
15 | Sahin F, Maitra A, Argani P, et al (2003). Loss of Stk11/Lkb1 expression in pancreatic and biliary neoplasms. Mod Pathol, 16, 686-91. DOI ScienceOn |
16 | Shackelford DB, Shaw RJ (2009). The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer, 9, 563-75. DOI ScienceOn |
17 | Shen Z, Wen XF, Lan F, Shen ZZ, Shao ZM (2002). The tumor suppressor gene LKB1 is associated with prognosis in human breast carcinoma. Clin Cancer Res, 8, 2085-90. |
18 | Su GH, Hruban RH, Bansal RK, et al (1999). Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am J Pathol, 154, 1835-40. DOI ScienceOn |
19 | Takeuchi Y, Ikeda F, Moritou Y, et al (2012). The impact of patatinlike phospholipase domain-containing protein 3 polymorphism on hepatocellular carcinoma prognosis. J Gastroenterol. |
20 |
Yang H, Zhai G, Ji X, et al (2012). LAPTM4B allele |
21 | Zha TZ, Hu BS, Yu HF, et al (2012). Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma. Tumour Biol, 33, 2125-34. DOI ScienceOn |
22 | Zhuang ZG, Di GH, Shen ZZ, Ding J, Shao ZM (2006). Enhanced expression of LKB1 in breast cancer cells attenuates angiogenesis, invasion, and metastatic potential. Mol Cancer Res, 4, 843-9. DOI ScienceOn |
![]() |